392 related articles for article (PubMed ID: 10499443)
1. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
Pei JJ; Braak E; Braak H; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443
[TBL] [Abstract][Full Text] [Related]
2. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
5. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.
Lau KF; Miller CC; Anderton BH; Shaw PC
Genomics; 1999 Sep; 60(2):121-8. PubMed ID: 10486203
[TBL] [Abstract][Full Text] [Related]
7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
8. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
Elyaman W; Terro F; Wong NS; Hugon J
Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
[TBL] [Abstract][Full Text] [Related]
9. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
11. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.
Pei JJ; Tanaka T; Tung YC; Braak E; Iqbal K; Grundke-Iqbal I
J Neuropathol Exp Neurol; 1997 Jan; 56(1):70-8. PubMed ID: 8990130
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
Baum L; Hansen L; Masliah E; Saitoh T
Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
16. GSK-3 is essential in the pathogenesis of Alzheimer's disease.
Takashima A
J Alzheimers Dis; 2006; 9(3 Suppl):309-17. PubMed ID: 16914869
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
[TBL] [Abstract][Full Text] [Related]
18. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
[TBL] [Abstract][Full Text] [Related]
19. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Shanavas A; Papasozomenos SC
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangles and tau phosphorylation.
Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]